(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
From Educational Loans to Obligation Free: Independence from the rat race Accomplished - 2Doritos and Cheetos debut 'NKD' options, without artificial colors or flavors
- 3What you need to know about flu treatments as cases spike across the US
- 4Slims down for Maintainable Weight reduction
- 5Nick Reiner's defense attorney asks to be replaced, again delaying arraignment in connection with the stabbing deaths of his parents, Rob Reiner and Michele Singer Reiner
- Hilary Duff announces new album ‘Luck… or Something,’ her first in over 10 years: ‘Excited is the largest understatement’
- Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
- Jason Kelce opens about wife Kylie Kelce's past pregnancy loss
- South Carolina's measles outbreak reaches 434 cases
- How to watch the last supermoon of the year
- The race to mine the moon is on – and it urgently needs some clear international rules
- Trial of pro-Palestine activist begins
- Andrew McCarthy's awe-inspiring image of a skydiver in front of the sun
- Congolese rape survivors search in vain for medicine after USAID cuts
